Tissue factor pathway inhibitor-2 (TFPI-2) is a 32 kDa matrix-associated Kunitz-type serine
proteinase inhibitor consisting of a short amino-terminal region, three tandem Kunitz-type …

Tissue factor pathway inhibitor-2 (TFPI-2), a member of the Kunitz-type serine proteinase
inhibitor family, is a structural homologue of tissue factor pathway inhibitor (TFPI). The …

Vasculogenic mimicry (VM), the formation of matrix-rich vascular-like networks in three-
dimensional culture corresponding with the expression of vascular cell-associated genes …

Idiopathic thrombosis often precedes the diagnosis of occult cancer by several years.
Whether hypercoagulability predisposes for malignancy or the converse holds true is an …

The placenta is a highly vascularized organ with fetal and maternal blood supply.
Syncytiotrophoblasts (STB), which line the placenta villous are possibly involved in local …

Abstract Matrix metalloproteinase 9 (MMP-9) is known to play a major role in cell migration
and invasion in both physiological and pathological processes. Our previous work has …

CD24 is a glycosyl-phosphatidylinositol-anchored protein with mucin-type structure that
resides exclusively in membrane microdomains. CD24 is often highly expressed in …

Tissue factor pathway inhibitor-2 (TFPI-2) is a Kunitz-type serine proteinase inhibitor that
inhibits plasmin-dependent activation of several metalloproteinases. Downregulation of TFPI …

The progression of neoplasms is frequently associated with thromboembolic complications.
Coagulation proteins, particularly tissue factor (TF), have been shown to play a role in tumor …

Human tissue factor pathway inhibitor-2 (TFPI-2) is a Kunitz-type serine protease inhibitor
that inhibits plasmin, trypsin, chymotrypsin, cathepsin G, and plasma kallikrein but not …